Civica
Financial intelligence for Asia's healthcare markets
 
 
Remember me:

Analysis: Quadria boosts Asian investments

Singapore-based private equity firm Quadria Capital is expanding its holdings in the region with investments into Vietnam and Singapore from its third investment vehicle, Quadria Capital Fund. Financial details were not disclosed for either transaction.

In Vietnam, it has completed an investment in HCM City-based FV Hospital. Founded by Jean-Marcel Guillon in 2003, the 220-bed hospital has more than 950 service staff, including 130 Vietnamese and expatriate doctors. It is the only joint commission international accredited hospital in South Vietnam. It also operates an outpatient clinic at the heart of District 1, HCM City’s traditional business district.

The investment will be used to build leading diagnostic and treatment centres for selected specialties and to provide access to advanced care in Central and South Vietnam via establishing an integrated network of healthcare facilities across the region.

Other investors who participated in the investment with Quadria include funds managed by Neuberger Berman Private Equity and DEG, the German development finance institution and a subsidiary of KfW.

In Singapore, it has taken a significant stake in MWH Holdings, the holding company for the Singapore Heart, Stroke and Cancer Centre. MWH currently operates out of Paragon Medical Centre and will be expanding its operations this year with a new centre located at Royal Square Novena.

It currently operates under four flagship brands: Singapore Heart, Stroke and Cancer Centre, a specialist centre focused on prevention, early diagnosis and treatment of heart disease, stroke and cancer; Singapore Medical Specialists Centre – multi-specialist centre offering a comprehensive range of specialty care services; Singapore Centre for Medical Imaging, a radiology centre offering a wide range of latest high-end diagnostics modalities; and Face, Body and Skin Aesthetics Medical Center, an aesthetics centre offering non-invasive, minimally invasive and surgical proceedures.

“Whilst we continue to serve the domestic and medical tourism segment out of Singapore, we see a significant opportunity regionally, particularly in the mid-tier segment where patients require something more affordable or for certain conditions where patients are unable to travel for treatment,” said Michael Lim, chief medical officer of MWH. And Quadria will support MWH’s regional growth ambitions through its existing hospital network and relationships.

Quadria Capital has assets exceeding US$1.5 billion and investments in 15 companies across the AsiaPacific region. It closed its third Quadria Capital Fund at US$304 million in June 2015 with two investments in Medica Synergie, the largest hospital network in eastern India, and SOHO Global Health, one of the largest pharmaceutical manufacturing and distribution businesses in Indonesia. The investments in Vietnam and Singapore are the sixth and seventh investments from that fund.

Posted on: 12/07/2017 UTC+08:00


News

Lilly Asia Ventures, which makes venture capital investments in Asia for global pharmaceutical giant Eli Lilly and Company, has closed LAV Biosciences Fund IV, its fourth fund. It took only two months to reach the hard cap of US$450 million.
Summerset Group, New Zealand’s third-largest listed retirement village operator, has posted a 78% jump in profits for the first half of the year of NZ$90.3 million (US$65.9 million).
Q&M Dental Group, which operates the largest network of private dental outlets in Singapore, has reported a decline in profits for the second quarter of the year, though these are the result of the deconsolidation of two subsidiaries.
Hong Kong-listed Common Splendor International Health Industry Group is currently juggling with two acquisitions in China.
IVD and medical imaging company Yestar Healthcare has said that it is in the preliminary stage of possibly acquiring medical device companies in the northern region of China.
Paragon Care, a leading distributor and manufacturer supplying medical equipment to hospitals, has agreed to acquire Medtek for A$649,000 (US$512,759) shares and cash. The company provides biomedical engineering services and preventative maintenance to the medical, scientific, aged care and allied health clients in the Far North Queensland region.
Hospital operation and management group the Hospital Corporation of China (HCC) plans to buy a 70% stake in an unnamed traditional Chinese medicine private hospital in Zhejiang.
For the first half of the year private specialist healthcare provider Singapore Medical Group (SMG) has reported a massive jump in profits on the back of its move into diagnostics and aesthetics.



Analysis

Mercer’s Catherine Li explains how companies in China can avoid common pitfalls when they establish employee health management programmes.
Lieven Jacquemyn, PPP international development director at GE Healthcare Singapore, discusses how governments, providers and investors can work together to bring universal health coverage to the region.
Mercer’s Rose Kwan and Heena Sethi explain how employers can better manage their healthcare benefits.
Susann Roth, senior social development specialist, Asian Development Bank, looks at financing mechanisms to meet the third Sustainable Development Goal.
On the back of an ageing population, strong employment growth and the flow of private investment, medical and health care property will emerge as a major asset class in Western Australian’s commercial property markets according to new analysis by independent West Australian commercial property information and research firm, Y Research.
In the second part of our two-part series, Bart Van den Mooter, CEO of the TforG Group, and Helgert van Raamt, vp partnerships and new business at TforG Group, look at the medtech opportunities in China.
In part one of a two-part series, Bart Van den Mooter, CEO of the TforG Group, and Helgert van Raamt, vp partnerships and new business at TforG Group, look at the impact of reforms on medtech in China.
In what is starting to resemble a comedy of errors, Wenzhou Kangning Hospital, the largest private psychiatric specialty care service provider in China, is having to start work yet again for its A-share offering.


Civica

HealthInvestor Asia Summit

AON

Podcasts

Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices